scispace - formally typeset
G

Gideon Koren

Researcher at Ariel University

Publications -  2007
Citations -  88165

Gideon Koren is an academic researcher from Ariel University. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 129, co-authored 1994 publications receiving 81718 citations. Previous affiliations of Gideon Koren include McGill University Health Centre & University of Western Ontario.

Papers
More filters
Journal ArticleDOI

Maternal and foetal outcome following Hodgkin's disease in pregnancy.

TL;DR: Pregnant women with Hodgkin's Disease had similar distribution of stages to the controls and their outcome with non-pregnant matched women who were of similar stage of disease, age at diagnosis, and calenderic year of treatment was not different.
Journal ArticleDOI

Folic acid food fortification is associated with a decline in neuroblastoma.

TL;DR: Results of previous studies have suggested that maternal vitamin intake may decrease the risk of several childhood cancers, and Canada began fortifying flour with folic acid for the prevention of neural tube defects in January 1997.
Journal ArticleDOI

Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto.

TL;DR: It is concluded that certain FAEE are present at measurable levels in the meconium of neonates not exposed to maternal drinking, and correction is needed to allow high specificity.
Journal ArticleDOI

Probiotics for Infantile Colic: A Randomized, Double-Blind, Placebo-Controlled Trial Investigating Lactobacillus reuteri DSM 17938

TL;DR: Administration of L reuteri DSM 17938 significantly improved colic symptoms by reducing crying and fussing times in breastfed Canadian infants with colic.
Journal ArticleDOI

Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children.

TL;DR: Low systemic exposure to oral mercaptopurine during maintenance therapy for acute lymphocytic leukemia in childhood adversely affects prognosis, and children should be studied at the beginning of maintenance therapy to establish the pharmacokinetics of merc laptopurine and the dose should be tailored to achieve an appropriate systemic exposure.